Videos | Page 4

Diabetes-Management-Can-Reduce-Employer-Health-Care-Costs
Jonathan G. Marquess, PharmD, CDE, explains that employers can save a great deal on health care costs by helping their employees with diabetes effectively manage their condition.
Hydrocodone-Combination-Product-Rescheduling-The-Bigger-Picture
Jeff Fudin, PharmD, FCCP, argues that the way to make hydrocodone combination products safer for patients is to provide more education for those who prescribe the medications and pharmacists who dispense them.
Why-Should-Hydrocodone-Combination-Products-Be-Categorized-as-CII-Drugs
Mary Lynn McPherson, PharmD, explains why hydrocodone combination products should no longer be categorized as Schedule III drugs.
Codeine-and-Rescheduling-Hydrocodone-Combination-Products
Jeff Fudin, PharmD, FCCP, argues that categorizing hydrocodone combination products as Schedule II could lead to increased prescription of codeine, a much “sloppier” drug that could create problems for patients.
Rescheduling-Hydrocodone-Combination-Products-Will-Lead-to-More-Responsible-Use
Mary Lynn McPherson, PharmD, argues that rescheduling hydrocodone combination products will lead to more responsible prescribing of the drugs and monitoring of their use.
Rescheduling-Hydrocodone-Combination-Products-Lessons-from-New-York-State
Jeff Fudin, PharmD, FCCP, discusses the effect of rescheduling hydrocodone combination products as CII in New York State on prescription of other opioids, including oxycodone.
How-Rescheduling-Hydrocodone-Combination-Products-Will-Reduce-Abuse
Mary Lynn McPherson, PharmD, explains how rescheduling hydrocodone combination products as Schedule II drugs will help reduce levels of abuse.
Abuse-Liability-of-Hydrocodone-Combination-Products
Jeff Fudin, PharmD, FCCP, argues that studies comparing the abuse liability of hydrocodone combination products with that of other opioids have produced conflicting results.
Rationale-for-Categorizing-Hydrocodone-Combination-Products-as-Schedule-III
Mary Lynn McPherson, PharmD, discusses why hydrocodone combination products were categorized as Schedule III in the first place.
Will-Rescheduling-Hydrocodone-Combination-Products-Actually-Reduce-Abuse
Jeff Fudin, PharmD, FCCP, argues that categorizing hydrocodone combination products as Schedule II drugs is unlikely to reduce abuse of the medications.
$AD300x250BB$
Latest Issues
$auto_registration$